May 6, 2021

enlamichoacana

Be Part Of Marketing

Deciphera Pharmaceuticals, Inc. to Present at the Guggenheim Healthcare Talks 2021 Notion Forum Oncology Day

1 min read

&#13
Deciphera Prescription drugs, Inc. (NASDAQ: DCPH) these days introduced that Steve Hoerter, President and Chief Govt Officer, will participate in a fireplace chat at the Guggenheim Healthcare Talks 2021 Notion Forum Oncology Working day on February 11, 2021 at 11:00 AM ET. The convention will be held in a digital assembly format.&#13

&#13
A live webcast of the event will be out there on the “Activities and Presentations” website page in the “Investors” section of the Company’s web-site at https://traders.deciphera.com/information-occasions/gatherings-displays. A replay of the webcast will be archived on the Company’s internet site for 90 times pursuing the presentation.&#13

&#13
About Deciphera Prescription drugs&#13

&#13
Deciphera is a biopharmaceutical enterprise concentrated on getting, creating and commercializing essential new medications to make improvements to the lives of persons with most cancers. We are leveraging our proprietary change-manage kinase inhibitor platform and deep know-how in kinase biology to create a broad portfolio of revolutionary medicines. In addition to advancing a number of product candidates from our platform in scientific scientific studies, QINLOCK is Deciphera’s Fda-accepted swap-manage kinase inhibitor for the treatment of fourth-line gastrointestinal stromal tumor (GIST). QINLOCK is also accredited for fourth-line GIST in Canada and Australia. For additional details, pay a visit to www.deciphera.com and abide by us on LinkedIn and Twitter (@Deciphera).&#13

&#13

enlamichoacana.com © All rights reserved. | Newsphere by AF themes.